Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
30 hedge funds and large institutions have $87.8M invested in Enzymotec Ltd in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 7 closing their positions.
0% more funds holding
Funds holding: 30 → 30 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
8% less capital invested
Capital invested by funds: $95.2M → $87.8M (-$7.38M)
Top Buyers
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$871K |
| 2 |
Renaissance Technologies
New York
|
-$320K |
| 3 |
Goldman Sachs
New York
|
-$316K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$305K |
| 5 |
TM
Tiger Management
New York
|
-$172K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Bank of America
Charlotte,
North Carolina
| $4K | -$871K | -100,000 | -100% |
|
27
UBS Group
Zurich,
Switzerland
| $3K | -$12.1K | -1,384 | -79% |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
29
Geode Capital Management
Boston,
Massachusetts
| $114 | +$110K | +12,640 | New |
|
|
PCM
30
Penserra Capital Management
Orinda,
California
| $18 | +$5.99K | +687 | +50% |
|
|
31
Wells Fargo
San Francisco,
California
| – | -$305K | -31,145 | Closed |
|
|
SIM
32
Spark Investment Management
New York
| – | -$149K | -15,300 | Closed |
|
|
ARTA
33
A.R.T. Advisors
New York
| – | -$113K | -11,569 | Closed |
|
34
Walleye Trading
New York
| – | -$70K | -7,100 | Closed |
|
|
PCM
35
Prelude Capital Management
New York
| – | -$39K | -4,021 | Closed |
|
|
TRCT
36
Tower Research Capital (TRC)
New York
| – | -$1K | -147 | Closed |
|
ENZY Hedge Fund Activity: Q1 2016 in Review
30 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q1 2016, worth a combined $87.8M — down 7.8% from $95.2M a quarter earlier.
Fund positioning in ENZY was balanced in Q1 2016: 7 funds opened new positions, 7 closed out, 8 added to existing stakes and 8 trimmed.
The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $1.21M. The largest seller was Bank of America, cutting an estimated $871K.
- 30 institutional investors held Enzymotec Ltd (ENZY) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $87.8M of Enzymotec Ltd stock for Q1 2016, down 7.8% quarter-over-quarter.
- 7 funds opened new Enzymotec Ltd positions in Q1 2016 and 7 closed out, a net change of 0 holders.
- The largest Enzymotec Ltd buyer in Q1 2016 was Janus Henderson Investors US, an estimated $1.21M added.
- The largest Enzymotec Ltd seller in Q1 2016 was Bank of America, an estimated $871K sold.
Based on aggregated 13F filings for Q1 2016.